Home › Male Infertility › NCT05479474
Platelet Rich Plasma Testis Treatment for Infertile Men
Platelet Rich Plasma Testis
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy Exclusion Criteria: \-
About the study
Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.
What is being tested
- Platelet rich plasma (biological)
Sponsor: Stanford University · Participants: 10 · Started: Jan 18, 2023
Contact the study team
- Satvir Basran · Phone: 650-723-0948
Official record on ClinicalTrials.gov — NCT05479474
Locations in the U.S.
| California | Stanford Urology Clinic, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.